Expressive

rs12226313 - LINC02750

Magnitude 2.2 · 1 study on file

Reported associations

  • Genome-wide association study and trans-ethnic meta-analysis identify novel susceptibility loci for type 2 diabetes mellitus - Unknown journal (n.d.) · Unknown authors · PubMed 38685053

    ABSTRACT: Background The genetic basis of type 2 diabetes (T2D) is under-investigated in the Middle East, despite the rapidly growing disease prevalence. We aimed to define the genetic determinants of T2D in Qatar. Methods Using whole genome sequencing of 11,436 participants (2765 T2D cases and 8671 controls) from the population-based Qatar Biobank (QBB), we conducted a genome-wide association study (GWAS) of T2D with and without body mass index (BMI) adjustment. Results We replicated 93 known T2D-associated loci in a BMI-unadjusted model, while 96 known loci were replicated in a BMI-adjusted model. The effect sizes and allele frequencies of replicated SNPs in the Qatari population generally concurred with those from European populations. We identified a locus specific to our cohort locate

Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.

Lifestyle context

Concrete actions anchored to the cited research. We do not prescribe, we describe.

Diet

  • minimize refined carbohydrates and added sugars Moderate

    Refined carbohydrates increase postprandial glucose spikes and insulin demand; individuals with genetic T2D risk require tighter glycemic control

    Prefer whole grains, legumes, vegetables; limit white bread, sugary cereals, sweetened beverages

Lifestyle

  • regular aerobic exercise for glucose control Moderate

    Physical activity improves insulin sensitivity and glucose tolerance; critical for individuals with genetic diabetes predisposition

    150 minutes moderate-intensity aerobic exercise per week plus resistance training 2-3 times weekly

Screening

  • fasting glucose and HbA1c screening Moderate

    Genetic variant associated with increased type 2 diabetes risk; early detection enables preventive intervention

    Annual fasting glucose and HbA1c testing starting age 30-40, or per clinician